Oral talactoferrin extends survival in patients with refractory NSCLC in a randomized, placebo-controlled, phase 2 trial

被引：1
|
作者：
Parikh, Purvish M.
Wang Yenyun
Ranade, A. A.
Vaid, A. K.
Advani, S. H.
Raghunadharao, D.
Nag, S.
Madhavan, J. P.
Varadhachary, Atul
机构：
[1] Tata Mem Hosp, Bombay 400012, Maharashtra, India
[2] Agennix Inc, Houston, TX USA
[3] Deenanath Mangeshkar Hosp, Pune, Maharashtra, India
[4] Rajeev Gandhi Canc Inst, Delhi, India
[5] Jaslok Hosp, Bombay, Maharashtra, India
[6] Nizams Inst, Hyderabad, Andhra Pradesh, India
[7] Jehangir Hosp, Pune, Maharashtra, India
[8] Reg Canc Ctr, Trivandrum 695011, Kerala, India
[9] Agnenix Inc, Houston, TX USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2007年 / 2卷 / 08期
关键词：
D O I：
10.1097/01.JTO.0000283192.54791.45
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S360 / S360
页数：1
相关论文
共 50 条
  • [41] Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
    Kronborg, Thit M.
    Schierwagen, Robert
    Trost, Kajetan
    Gao, Qian
    Moritz, Thomas
    Bendtsen, Flemming
    Gantzel, Rasmus H.
    Andersen, Mette L.
    Teisner, Ane S.
    Gronbaek, Henning
    Hobolth, Lise
    Moller, Soren
    Trebicka, Jonel
    Kimer, Nina
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (12)
  • [42] Roflumilast in Asian patients with COPD: A randomized placebo-controlled trial
    Lee, Sang-Do
    Hui, David S. C.
    Mahayiddin, Aziah A.
    Roa, Camilo C., Jr.
    Kwa, Kheng Hoe
    Goehring, Udo-Michael
    Bredenbroeker, Dirk
    Kuo, Han-Pin
    RESPIROLOGY, 2011, 16 (08) : 1249 - 1257
  • [43] A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
    Saad, F
    Gleason, DM
    Murray, R
    Tchekmedyian, S
    Venner, P
    Lacombe, L
    Chin, JL
    Vinholes, JJ
    Goas, JA
    Chen, B
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (19): : 1458 - 1468
  • [44] A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis
    Giovannoni, Gavin
    Knappertz, Volker
    Steinerman, Joshua R.
    Tansy, Aaron P.
    Li, Thomas
    Krieger, Stephen
    Uccelli, Antonio
    Uitdehaag, Bernard M. J.
    Montalban, Xavier
    Hartung, Hans-Peter
    Pia Sormani, Maria
    Cree, Bruce A. C.
    Lublin, Fred
    Barkhof, Frederik
    NEUROLOGY, 2020, 95 (08) : E1027 - E1040
  • [45] A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis (vol 41, pg 706, 2013)
    Guntupalli, K.
    Dean, N.
    Morris, P. E.
    CRITICAL CARE MEDICINE, 2014, 42 (05) : E390 - E390
  • [46] Acetylsalicylic Acid Treatment in Patients With Sepsis and Septic Shock: A Phase 2, Placebo-Controlled, Randomized Clinical Trial
    Almeida, Thiago M. L.
    Freitas, Flavio G. R.
    Figueiredo, Rodrigo C.
    Houly, Sandra G.
    Azevedo, Luciano C. P.
    Cavalcanti, Alexandre B.
    Damiani, Lucas P.
    Svicero, Bianca S.
    Souza, Maria A.
    Bustamante, Cintia L. S.
    Ramos, Fernando J. S.
    Alves, Rafael S. V.
    Atallah, Fernanda C.
    Jackiu, Miriam
    Pacheco, Eduardo S.
    Schmidt, Raysa C.
    Serra, Felipe S. C.
    Tomotani, Daniere Y. V.
    Zampieri, Fernando G.
    Machado, Flavia R.
    BRICNET
    CRITICAL CARE MEDICINE, 2025, 53 (02) : e269 - e281
  • [47] High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial
    Schreiber, Karen
    Magyari, Melinda
    Sellebjerg, Finn
    Iversen, Pernille
    Garde, Ellen
    Madsen, Camilla Gobel
    Bornsen, Lars
    Christensen, Jeppe Romme
    Ratzer, Rikke
    Siebner, Hartwig Roman
    Laursen, Bjarne
    Sorensen, Per Soelberg
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (05) : 675 - 685
  • [48] SEMAGLUTIDE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: SUBGROUP ANALYSIS OF A RANDOMIZED, PLACEBO-CONTROLLED PHASE 2 TRIAL
    Francque, Sven M.
    Kjaer, Mette Skalshoi
    Ladelund, Steen
    Okanoue, Takeshi
    Mateva, Lyudmila
    Shrestha, Ichhya
    Harrison, Stephen A.
    HEPATOLOGY, 2021, 74 : 1123A - 1124A
  • [49] Vidofludimus Calcium in Patients With Moderate-to-Severe Ulcerative Colitis: A Randomized, Placebo-Controlled, Phase 2 Trial
    D'Haens, Geert
    Stardelova, Kalina Grivcheva
    Sadiku, Edite
    Kizlova, Natallia
    Skybalo, Syitlana
    Shehovtsova, Yulia
    Abramescu, Mirela
    Vitt, Daniel
    Kohlhof, Hella
    Muehler, Andreas
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2025, 16 (03)
  • [50] MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemia
    Montesinos, Pau
    Beckermann, Benjamin M.
    Catalani, Olivier
    Esteve, Jordi
    Gamel, Katia
    Konopleva, Marina Y.
    Martinelli, Giovanni
    Monnet, Annabelle
    Papayannidis, Cristina
    Park, Aaron
    Recher, Christian
    Rodriguez-Veiga, Rebeca
    Roellig, Christoph
    Vey, Norbert
    Wei, Andrew H.
    Yoon, Sung-Soo
    Fenaux, Pierre
    FUTURE ONCOLOGY, 2020, 16 (13) : 807 - 815
12345